Dr. Dan Kaufman and his laboratory received one of the two $2.1 million CIRM grants. The normal immune system contains natural killer (NK) cells; Dr. Kaufman and coworkers are using induced human pluripotent stem cells (iPSCs) to produce NK cells that can target specific tumors, such as ovarian cancer, with high specificity.
Dan Kaufman, MD, PhD, is Professor of Medicine in the Division of Regenerative Medicine and Director of Cell Therapy at UC San Diego School of Medicine.